Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02107950
Recruitment Status : Completed
First Posted : April 8, 2014
Last Update Posted : August 15, 2018
Sponsor:
Information provided by (Responsible Party):
Sotio a.s.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2016
  Actual Study Completion Date : May 17, 2017